278 related articles for article (PubMed ID: 3022583)
1. Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1986 Oct; 81(4C):36-9. PubMed ID: 3022583
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
3. Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M; Kessler PD; Gottlieb SS
Am J Med; 1987 Jun; 82(6):1119-26. PubMed ID: 3037896
[TBL] [Abstract][Full Text] [Related]
4. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Galvao M
Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
Kubo SH; Cody RJ
Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
[TBL] [Abstract][Full Text] [Related]
7. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
Abrams WB; Davies RO; Ferguson RK
Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
[TBL] [Abstract][Full Text] [Related]
8. When and how to use angiotensin-converting enzyme inhibition in congestive heart failure.
Rydén L
Am J Cardiol; 1988 Jul; 62(2):75A-80A. PubMed ID: 2839022
[TBL] [Abstract][Full Text] [Related]
9. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
Lantz P; Enghoff E; Hedlund A; Hägg A
Scand J Urol Nephrol Suppl; 1984; 79():129-32. PubMed ID: 6089312
[TBL] [Abstract][Full Text] [Related]
11. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
12. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
Packer M; Medina N; Yushak M; Lee WH
Br Heart J; 1985 Sep; 54(3):298-304. PubMed ID: 2994697
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
15. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Cody RJ; Laragh JH; Atlas SA; Case DB
J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure.
DiBianco R
Postgrad Med; 1985 Oct; 78(5):229-41, 244, 247-8. PubMed ID: 2864682
[TBL] [Abstract][Full Text] [Related]
17. Evolution of angiotensin-converting enzyme inhibitors.
Wyvratt MJ
Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Cody RJ
Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
[TBL] [Abstract][Full Text] [Related]
19. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
Cody RJ; Laragh JH
Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
[TBL] [Abstract][Full Text] [Related]
20. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Giles TD; Fisher MB; Rush JE
Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
